Department of Diagnostic and Interventional Neuroradiology, Klinikum Rechts der Isar, Technical University Munich, Ismaninger Straße 22, 81675, Munich, Germany.
Department of Hematology and Oncology, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.
J Neurol. 2019 Jul;266(7):1588-1595. doi: 10.1007/s00415-019-09295-z. Epub 2019 Mar 27.
Acute ischemic stroke (AIS) has well-known risk factors. The role of platelets in patients treated using mechanical thrombectomy (MT) has not been studied. The aim of this study was to study if there is an association of initial thrombocytopenia (TP) and a decline of platelets counts (DPC) with the clinical outcomes, mortality and intracranial hemorrhage (ICH) rates in AIS patients treated with MT.
In a case-control study consecutive MT-stroke patients were analyzed. A multivariate logistic regression model was used to test for good clinical outcome (mRS 90 days <= 2) and mortality adjusting for age, initial NIHSS, pretreatment with tPA, statins and platelet inhibitors, occlusion site, time from symptom onset to recanalization, initial TP (< 150 × 10/L) and DPC (> 26%). Additionally, rates of ICH were compared.
Of 294 patients included, 9.6% had an initial TP and 23.8% a DPC > 26%. The mortality rate in patients with normal platelet counts was 26.1% vs. 48.3% (p = 0.002) in patients with initial TP with an aOR of 3.47 (CI 1.28-9.4, p = 0.005). No difference regarding the rate of good clinical outcome (p = 0.204) and ICH (p = 0.18) was observed. A DPC of more than 26% during the first 5 days of hospitalization predicted the rate of mortality (aOR 2.4 CI 1.14-5.04, p = 0.021) and the chances of a good clinical outcome (aOR 0.291 CI 0.128-0.666, p = 0.003) without significant differences of ICH rates (p = 0.735).
In AIS patients treated with MT an initial TP was independently associated with higher mortality rates and a marked DPC with higher mortality rates as well as poorer clinical outcomes.
急性缺血性脑卒中(AIS)有明确的危险因素。血小板在接受机械取栓(MT)治疗的患者中的作用尚未得到研究。本研究旨在研究 AIS 患者接受 MT 治疗后,初始血小板减少症(TP)和血小板计数下降(DPC)与临床结局、死亡率和颅内出血(ICH)发生率之间是否存在关联。
在一项连续 MT 脑卒中患者的病例对照研究中,我们使用多变量逻辑回归模型,调整年龄、初始 NIHSS、tPA 预处理、他汀类药物和血小板抑制剂、闭塞部位、症状发作至再通时间、初始 TP(<150×10/L)和 DPC(>26%)等因素,来检验良好临床结局(90 天 mRS 评分≤2)和死亡率。此外,还比较了 ICH 发生率。
294 例患者中,9.6%存在初始 TP,23.8%存在 DPC>26%。血小板计数正常的患者死亡率为 26.1%,而初始 TP 的患者死亡率为 48.3%(p=0.002),校正后的比值比(OR)为 3.47(95%CI 1.28-9.4,p=0.005)。两组患者的良好临床结局率(p=0.204)和 ICH 发生率(p=0.18)无差异。住院前 5 天内 DPC>26%预测死亡率(校正 OR 2.4,95%CI 1.14-5.04,p=0.021)和良好临床结局的可能性(校正 OR 0.291,95%CI 0.128-0.666,p=0.003),而 ICH 发生率无显著差异(p=0.735)。
在接受 MT 治疗的 AIS 患者中,初始 TP 与更高的死亡率独立相关,而显著的 DPC 与更高的死亡率以及更差的临床结局相关。